China’s Biotheus Advances Biologics Therapies With New Financing
Founded in 2018, Biotheus is a Zhuhai, China-based clinical development stage company with the mission of treating cancer and autoimmune diseases through next-generation therapeutics. The company’s product pipeline consists of over ten novel monoclonal and multispecific antibodies focused on curing malignant tumors and autoimmune diseases. Biotheus currently has two bispecific antibodies in phase I clinical … Read more